List of works - Gustavo Cabral-Miranda

A Single Monoclonal Antibody against the Peanut Allergen Ara h 2 Protects against Systemic and Local Peanut Allergy

scientific article published on 10 March 2020

Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines

scientific article published on 06 March 2017

Biosensor-based selective detection of Zika virus specific antibodies in infected individuals

scientific article published in May 2018

Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

scientific article published on 23 May 2019

Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72

scientific article published on 20 February 2020

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines

scientific article

Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination.

scientific article published on 28 February 2017

Detecting circulating antibodies by controlled surface modification with specific target proteins: Application to malaria

scientific article published on 15 January 2017

Discovery of four new B-cell protective epitopes for malaria using Q beta virus-like particle as platform

scientific article published on 08 October 2020

Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands-A Role for CCL2

scientific article published on 02 August 2019

Major findings and recent advances in virus-like particle (VLP)-based vaccines

scientific article published on 5 September 2017

Microcrystalline Tyrosine (MCT®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria

scientific article published on 27 September 2017

Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine.

scientific article published on 15 May 2019

Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus

scientific article published on 02 March 2020

Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

scientific article published on 26 April 2019

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax